Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-26 @ 5:28 AM
Study NCT ID:
NCT05288660
Status:
COMPLETED
Last Update Posted:
2023-05-09
First Post:
2022-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of a Single Dose of ALXN1210 in Healthy Participants
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-11
First Submit QC Date:
None
Study First Post Date:
2022-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-30
Results First Submit QC Date:
None
Results First Post Date:
2023-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-30
Last Update Post Date:
2023-05-09
Last Update Post Date Type:
ACTUAL